Ultravist - 50419-340-05 - (iopromide)

Alphabetical Index


Drug Information of Ultravist

Product NDC: 50419-340
Proprietary Name: Ultravist
Non Proprietary Name: iopromide
Active Ingredient(s): 311.7    mg/mL & nbsp;   iopromide
Administration Route(s): INTRA-ARTERIAL; INTRAVENOUS
Dosage Form(s): INJECTION
Coding System: National Drug Codes(NDC)

Labeler Information of Ultravist

Product NDC: 50419-340
Labeler Name: Bayer HealthCare Pharmaceuticals Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020220
Marketing Category: NDA
Start Marketing Date: 20091230

Package Information of Ultravist

Package NDC: 50419-340-05
Package Description: 10 VIAL, GLASS in 1 CARTON (50419-340-05) > 50 mL in 1 VIAL, GLASS

NDC Information of Ultravist

NDC Code 50419-340-05
Proprietary Name Ultravist
Package Description 10 VIAL, GLASS in 1 CARTON (50419-340-05) > 50 mL in 1 VIAL, GLASS
Product NDC 50419-340
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name iopromide
Dosage Form Name INJECTION
Route Name INTRA-ARTERIAL; INTRAVENOUS
Start Marketing Date 20091230
Marketing Category Name NDA
Labeler Name Bayer HealthCare Pharmaceuticals Inc.
Substance Name IOPROMIDE
Strength Number 311.7
Strength Unit mg/mL
Pharmaceutical Classes Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]

Complete Information of Ultravist


General Information